Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension-Reference-Cited by-同舟云学术

Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension

Published:2020-05 Issue: Volume:306 Page:140-145
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Gu Jun,Yin Zhao-fang,Zhang Jun-feng,Wang Chang-qian

Funder

National Natural Science Foundation of China

Clinical Research Program of 9th People's Hospital

Shanghai Science and Technology Commission

Shanghai Shenkang Hospital Development Center

Shanghai Ninth People's Hospital

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891–975.

2. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction;Solomon;Eur. Heart J.,2016

3. Asymptomatic left ventricular diastolic dysfunction: predicting progression to symptomatic heart failure;Kosmala;JACC Cardiovasc Imaging,2019

4. Impact of improved glycemic control on cardiac function in type 2 diabetes mellitus;Leung;Circ Cardiovasc Imaging,2016

5. Metformin is associated with improved left ventricular diastolic function measured by tissue Doppler imaging in patients with diabetes;Andersson;Eur. J. Endocrinol.,2010

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impacts of Nirmatrelvir–Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic;Cardiovascular Drugs and Therapy;2024-03-11

2. The impacts of prophylactic anticoagulation therapy during hospitalization on long-term cardiovascular outcomes in high-risk COVID-19 patients amid the omicron wave of the pandemic;IJC Heart & Vasculature;2024-02

3. The Role of Selected Epigenetic Pathways in Cardiovascular Diseases as a Potential Therapeutic Target;International Journal of Molecular Sciences;2023-09-06

4. Myocardial Metabolic Reprogramming in HFpEF;Journal of Cardiovascular Translational Research;2023-08-31

5. Immunometabolism at the Heart of Cardiovascular Disease;JACC: Basic to Translational Science;2023-07